by sherry | Dec 20, 2021 | Press Release
“The joint study has confirmed that personalized PBM dosing is key to MDD treatment.” Irvine, Calif.—Niraxx Light Therapeutics, a leader in wearable neurotechnology, today announced recent study findings supporting the company’s personalized PBM...
by sherry | Feb 8, 2021 | Press Release
“We think the device’s wearability—ability to deliver treatment whenever and wherever—will change the care paradigm for depression.” Irvine, Calif. — Niraxx Light Therapeutics, a leader in wearable neurotechnology, today announced the initiation of a...
by sherry | Jan 15, 2021 | Press Release
“We now have preliminary evidence demonstrating that the Brain-Pacer-driven positive neural activity changes are real.” Irvine, Calif. — Niraxx Light Therapeutics, a leader in wearable neurotechnology, today announced positive initial results from its...
